Novel recombinant influenza vaccine showspromise in animal studies
Recombinant protein vaccines, exemplified by the Novavax vaccine deployed in combating COVID-19, present a plethora of advantages over traditional vaccines. Their precise manufacturability, coupled with enhanced safety and potential efficacy, as well as the prospect of reduced dosage requirements, underscores their pivotal role in modern immunization strategies. Given these attributes, there is burgeoning interest in … Read more